Display options
Cite
Chono S, Matsui M, Nakamura K, et al. Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets. J Pharm (Cairo). 2016;2016:6131608doi: 10.1155/2016/6131608.
Chono, S., Matsui, M., Nakamura, K., & Kasai, R. (2016). Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets. Journal of pharmaceutics, 20166131608. https://doi.org/10.1155/2016/6131608
Chono, Sumio, et al. "Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets." Journal of pharmaceutics vol. 2016 (2016): 6131608. doi: https://doi.org/10.1155/2016/6131608
Chono S, Matsui M, Nakamura K, Kasai R. Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets. J Pharm (Cairo). 2016;2016:6131608. doi: 10.1155/2016/6131608. Epub 2016 Dec 01. PMID: 28044122; PMCID: PMC5156814.
Copy Download .nbib Format: NLM
Share it on

J Pharm (Cairo). 2016;2016:6131608. doi: 10.1155/2016/6131608. Epub 2016 Dec 01.

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets.

Journal of pharmaceutics

Sumio Chono, Megumi Matsui, Katsuki Nakamura, Ryoya Kasai

Affiliations

  1. Division of Pharmaceutics, Hokkaido Pharmaceutical University School of Pharmacy, Hokkaido, Japan.
  2. Keihan Hospital, Osaka, Japan.

PMID: 28044122 PMCID: PMC5156814 DOI: 10.1155/2016/6131608

[No abstract available.]

Conflict of interest statement

The authors declare that there are no competing interests regarding the publication of this paper.

References

  1. Yakugaku Zasshi. 2010 Aug;130(8):1029-40 - PubMed

Publication Types